Global Peripheral Vascular Devices Market - Growth, Trends & Forecasts (2017 - 2022)

The Global peripheral vascular device market has been estimated at USD XX billion in 2015 and is projected to reach USD XX billion by 2020, at a CAGR of XX% during the forecast period from 2015 to 2021. Peripheral Vascular devices are used in the treatment of blood vessels outside of the brain and heart. The common peripheral vascular disease includes the plaque buildups which causes insufficient blood flow due to the narrowing of the arteries.

The number of patients who have peripheral artery occlusive disease is steadily increasing worldwide and thus the peripheral vascular device market is project to grow.

The global peripheral vascular device market is going to be driven by the rising demand for minimally invasive procedures, upsurge of peripheral vascular diseases, change in lifestyle and aging population and the technological advancement in the development of new devices. However, the market is restrained by stringent regulatory framework, reimbursement issues in many developing countries and the highly fragmented market.

The global peripheral vascular device market is segmented based on the product types into angioplasty balloons, stents, embolic protection devices, inferior vena cava filters, aortic stent grafts, synthetic surgical grafts, peripheral vascular accessory devices, PTA balloon catheters, vascular closure devices and chronic total occlusion (CTO) devices. The angioplasty balloon is further segmented based on products (normal, cutting, scoring and drug coated) and on the material used (non compliant and semi compliant types). Based on stents the market is further segmented as balloon expandable stent, self expandable stents and covered stents.

Based on geographical location, the peripheral vascular device market can be divided into North America (USA, Canada and Mexico), Europe (France, UK, Germany, Spain, Scandinavia, Portugal, BENELUX, and Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, and New Zealand), Middle East and Africa (GCC, Egypt) and Latin America (Brazil, and Argentina).

The growing use of bio-absorbable stents and the rise in health awareness and increasing expendable earnings are some market opportunities for the vendors. However, the cost of the procedure especially in developing countries and product failures which have been reported for many small players are some key challenges. The key market players in the global scenario are Abbot Laboratories, Angioscore, Boston Scientific Corporation, Bayer AG, Emboline INC among many others.

Key Deliverables

Market analysis for the global peripheral vascular device market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global vascular device market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped


1.1 Study deliveratives

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and forecasr period years

1.6 General Study Assumptions


2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric forecast models

2.4 Research Assumptions




5.1 Current market scenario

5.2 Technology Overview

5.3 New developments in therapeutics

5.4 Investment analysis

5.5 Porters Five Force Analysis

5.5.1 Bargaining Power of suppliers

5.5.2 Bargaining power of buyers

5.5.3 Degree of competition

5.5.4 Threat of substitution

5.5.5 Threat of new entrants


6.1 Market Drivers

6.1.1 Rising demand for miminally invasive procedures

6.1.2 Upsurge of Peripheral vascular diseases

6.1.3 Lifestyle changes and increase in the ageing population

6.1.4 Technological advancements

6.2 Market Restraints

6.2.1 Stringent Regulatory Framework

6.2.2 Reimbursement issues

6.2.3 Highly fragmented market

6.3 Market Opportunities

6.3.1 Growing use of bio-absorbable stents

6.3.2 Rise in health awareness and increasing expendable earnings

6.4 Key Challenges

6.4.1 Cost of the procedure especially in the developing countries

6.4.2 Product failures have been reported by many small players

7. Global peripheral vascular device market Segmentation

7.1 Angioplasty Balloons

7.1.1 Based on product Normal balloon Cutting balloon Scoring balloon Drug coated balloon

7.1.2 Based on material used Non-Compliant Balloons Semi-Compliant Balloons

7.2 Stents

7.2.1 Ballon expandable stent

7.2.2 Self expandable stents

7.2.3 Covered stents

7.3 Embolic Protection devices

7.4 Inferior Vena Cava filters

7.5 Aortic Stent Grafts

7.6 Synthetic Surgical Grafts

7.7 Peripheral Vascular Accessory Devices

7.8 PTA Balloon Catheters

7.9 Vascular Closure Devices

7.10 Chronic Total Occlusion (CTO) Devices

7.11 Others

8. Global peripheral vascular device market Georaphy - Regional shares and forecast

8.1 North America

8.1.1 Introduction

8.1.2 USA

8.1.3 Canada

8.1.4 Mexico

8.1.5 Rest of North America

8.2 Europe

8.2.1 Introduction

8.2.2 France

8.2.3 UK

8.2.4 Germany

8.2.5 Spain and Portugal

8.2.6 Italy

8.2.7 Scandinavia


8.2.9 Rest of Europe

8.3 Asia-Pacific

8.3.1 Introduction

8.3.2 India

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 Australia and New Zealand

8.3.7 Rest of Asia Pacific

8.4 Middle East and Africa

8.4.1 Introduction

8.4.2 GCC

8.4.3 Egypt

8.4.4 Rest of Middle East and Africa

8.5 Latin America

8.5.1 Introduction

8.5.2 Brazil

8.5.3 Argentina

8.5.4 Rest of Latin America COMPETITIVE LANDSCAPE


10. Abbott Laboratories

10.1 Angioscore

10.2 Boston Scientific Corporation

10.3 C.R.Bard, Inc.

10.4 Bayer AG

10.5 Biosensors International Group

10.6 Covidien PLC

10.7 Emboline INC

10.8 Ednologix

10.9 Lombard Medical Technologies Plc

10.10 Analyst outlook for Investment Opportunities

11. Future outlook of the market


13. Abbrevations

13.1 Bibliography

13.2 Disclaimer

Content are not available

Choose License Type